Using sequencing (and other assays) in clinical trials: FDA rules and regulations

Authors

E. David Litwack, FDA, Personalized Medicine Staff, Office of In Vitro Diagnostics

Document Type

Presentation

Publication Date

2014

Name of Conference

Personalized Medicine? Using sequencing (and other assays) in clinical trials: FDA rules and regulations

Recommended Citation

Litwack, E. David, "Using sequencing (and other assays) in clinical trials: FDA rules and regulations" (2014). 2014 Personalized Medicine? Using sequencing (and other assays) in clinical trials: FDA rules and regulations. Paper 3.
Retrieved from https://digitalcommons.wustl.edu/hrpoconf_personalizedmed_2014/3